EUVIMEDEUVIMED entdecken
Open Access

An Information Tool Incorporating Real-World Outcome Data for Women With Metastatic Breast Cancer Eligible for Treatment With a CDK4/6 Inhibitor: Development and Evaluation

Ellen G Engelhardt iD, Mariska Q N Hackert iD, Anne Vogelaar iD, Afke F de Jong iD, Cristina Guerrero Paez iD, Annette W G van der Velden iD, Christa Putker iD, Mariette J Agterof iD, Ewoudt M W van de Garde iD, Cornelia F van Uden-Kraan iD

JMIR Cancer · 30.07.2026 · 12 · e73156-e73156

DOI: 10.2196/73156 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JMIR Cancer, online erschienen am 30.07.2026. Verfasst von Ellen G Engelhardt und 9 weiteren Autor:innen. Beteiligte Einrichtung: Santeon (Netherlands), Herculesplein 102, Utrecht, 3584 AA, The Netherlands. Hauptthemen laut MEDLINE: Breast Neoplasms, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6, Protein Kinase Inhibitors. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Accelerating the transition to value-based health care (VBHC) is essential to ensure sustainable care delivery. VBHC maximizes patient value by optimizing outcomes, controlling costs, and leveraging data to improve quality and patient-doctor communication. Integrating real-world data in health care is important to achieve informed decisions, especially in palliative care, where choices are complex.

Objective

This study described the development and pilot-testing of an information tool that incorporates real-world outcome data for women with metastatic breast cancer who are initiating CDK4/6 inhibitor treatment. Real-world insights are needed to better inform these patients, in particular because real-world outcomes are known to differ from trial results because of larger heterogeneity in patient characteristics, and differences in frequency of check-ups and handling side effects.

Methods

We developed an information tool together with patient representatives and clinicians using a participatory development approach that consisted of five key steps: (1) establishment of a multidisciplinary steering group (n=10 steering group members), (2) mapping of the patient journey and patients’ needs through focus groups (n=9) and semistructured interviews (n=8), (3) extraction of real-world outcome data from electronic health records systems of 229 patients, (4) prototyping of the tool (n=10), and (5) pilot evaluation with the targeted patient population using semistructured interviews (n=38). We used qualitative analysis methods to analyze the focus group and interview data.

Results

We developed a tool consisting of (1) a communication aid for use during doctor-patient consultations (ie, KIJKgesprek [Stichting Kijksluiter]) and (2) a 2-component companion app with informational videos for use at home, both incorporating real-world outcome data (ie, KIJKbericht and KIJKsluiter [Stichting Kijksluiter]). Participants valued the tool for its clarity and structured design, reporting that the outcome data reinforced their experiences and facilitated the setting of realistic expectations. However, some participants described the outcome data as overwhelming, underscoring the importance of careful framing and delivery. Preferences regarding the type, level of detail, and timing of information presentation varied among participants, highlighting the necessity of individualizing information tools to meet diverse informational needs.

Conclusions

Most patients valued the inclusion of real-world outcome data in the information tool, although many found it challenging to process. Preferences for the type and presentation of information varied widely among individuals. Information tools incorporating outcome data have the potential to enhance patient understanding and support informed decision-making about care that they value most. However, these tools must be designed to allow for customization, ensuring they address individual informational needs and preferences effectively.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCyclin-Dependent Kinase 4Cyclin-Dependent Kinase 6Protein Kinase InhibitorsHumansFemaleMiddle AgedAdultAgedValue-Based Health CareFocus GroupsPilot ProjectsNeoplasm Metastasis

Stichwörter der Autor:innen

CDK4/6 inhibitoradvanced breast cancerinformation toolreal world outcome datavalue-based health care

Substanzen

Cyclin-Dependent Kinase 4Cyclin-Dependent Kinase 6Protein Kinase InhibitorsCDK4 protein, humanCDK6 protein, human

Autor:innen und Institutionen

  • Santeon (Netherlands), Herculesplein 102, Utrecht, 3584 AA, The Netherlands.
  • Stichting Kijksluiter, Amsterdam, The Netherlands.
  • Borstkankervereniging Nederland, Utrecht, The Netherlands.
  • Department of Internal Medicine, Martini Ziekenhuis, Groningen, The Netherlands.
  • Department of Internal Medicine, St. Antonius Hospital, Utrecht/Nieuwegein, The Netherlands.
  • Department of Pharmacy, St. Antonius Hospital, Utrecht/Nieuwegein, The Netherlands.

ORCID-Profile: Ellen G Engelhardt, Mariska Q N Hackert, Anne Vogelaar, Afke F de Jong, Cristina Guerrero Paez, Annette W G van der Velden, Christa Putker, Mariette J Agterof, Ewoudt M W van de Garde, Cornelia F van Uden-Kraan

Zitieren

APA

Engelhardt, E. G., Hackert, M. Q. N., Vogelaar, A., de Jong, A. F., Guerrero Paez, C., van der Velden, A. W. G., Putker, C., Agterof, M. J., van de Garde, E. M. W., & van Uden-Kraan, C. F. (2026). An Information Tool Incorporating Real-World Outcome Data for Women With Metastatic Breast Cancer Eligible for Treatment With a CDK4/6 Inhibitor: Development and Evaluation. JMIR Cancer, 12, e73156-e73156. https://doi.org/10.2196/73156

Vancouver

Engelhardt EG, Hackert MQN, Vogelaar A, de Jong AF, Guerrero Paez C, van der Velden AWG, et al. An Information Tool Incorporating Real-World Outcome Data for Women With Metastatic Breast Cancer Eligible for Treatment With a CDK4/6 Inhibitor: Development and Evaluation. JMIR Cancer. 2026;12:e73156-e73156. doi:10.2196/73156

BibTeX
@article{Engelhardt2026,
  author = {Engelhardt, Ellen G and Hackert, Mariska Q N and Vogelaar, Anne and de Jong, Afke F and Guerrero Paez, Cristina and van der Velden, Annette W G and Putker, Christa and Agterof, Mariette J and van de Garde, Ewoudt M W and van Uden-Kraan, Cornelia F},
  title = {An Information Tool Incorporating Real-World Outcome Data for Women With Metastatic Breast Cancer Eligible for Treatment With a CDK4/6 Inhibitor: Development and Evaluation},
  journal = {JMIR Cancer},
  year = {2026},
  volume = {12},
  pages = {e73156--e73156},
  doi = {10.2196/73156}
}
Kostenlos starten →